Be Biopharma logo

Be Biopharma

Cambridge, MA

Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.

be.bio

Company Details

Founded

2020

Employees

Between 50 - 100 employees

Raised

$356,000,000

Headquarters Location

Cambridge, MA

Public

No

Acquired

No

CEO

David SteinbergDavid Steinberg

Founders

David Steinberg
David Steinberg
David Rawlings
David Rawlings
Lea Hachigian
Lea Hachigian
Aleks Radovic-Moreno
Aleks Radovic-Moreno
Rich James
Rich James

Company Collections

These are collections Be Biopharma is a part of. Click on the collection name to view similar companies.

Be Biopharma's Industries

Be Biopharma's Tech Stack

Be Biopharma Headquarters Location

B200 Suite 001, Cambridge, MA 02139

Total Amount Raised: $356,000,000

Be Biopharma Funding Rounds

  • Series C

    $92,000,000

    Series C Investors

    Bristol Myers Squibb
    Longwood Fund
    Nextech Invest
    Arch Venture Partners
    Atlas Venture
    Alta Partners
    RA Capital Management
    Takeda Ventures

  • Series Unknown

    $82,000,000

    Series Unknown Investors

    Arch Venture Partners
    Takeda Ventures
    RA Capital Management
    Atlas Venture
    Alta Partners
    Bristol Myers Squibb
    Longwood Fund

  • Series B

    $130,000,000

    Series B Investors

    Arch Venture Partners
    Takeda Ventures
    Longwood Fund
    RA Capital Management
    Alta Partners
    Atlas Venture
    Bristol Myers Squibb

  • Series A

    $52,000,000

    Series A Investors

    Atlas Venture
    RA Capital Management
    Takeda Ventures
    Longwood Fund
    Alta Partners
Funding info provided by Diffbot.

Be Biopharma Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Be Biopharma.

Recent reviews